GBS Global Biopharma has:
- Four patents issued in the US with corresponding patents issued internationally
- Seven nonprovisional patent applications pending in the US
- Four provisional patent applications pending in the US
- Three licensed patents
- 29 patent applications filed internationally
This intellectual property portfolio contains formulations to treat the following conditions.